ArticleGut microbes reports2025
Gut microbial dysbiosis activates the classical complement pathway in a short-term morphine treatment model.
Article in Gut microbes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Antibodies play an essential role in preserving intestinal homeostasis in healthy and dysbiotic states. Recent studies demonstrate that a microbiome-dependent intestine-specific complement system maintains intestinal homeostasis. Morphine induces microbial dysbiosis within hours of administration characterized by the expansion of pathogenic bacteria with a concurrent decrease in commensal bacteria. A murine model of short-term morphine treatment was used to provide insights into the early immune processes during microbial dysbiosis. Within 24 h, morphine treatment upregulates the expression of classical complement pathway genes in intestinal tissue, with a concurrent increase in the complement proteins C1q and C3 in the ileal luminal content. Importantly, a parallel increase in the concentration of complement-activating antibodies IgM and IgG is observed in the ileal luminal content at 24 h. The increased concentration of complement proteins and antibodies are dependent on the microbiome, as microbial depletion prior to morphine treatment abolishes this increase. Finally, intestinal infiltration and activation of neutrophils is observed concurrent with microbial dysbiosis. This study demonstrates rapid microbiome-dependent intestinal recruitment of complement machinery during microbial dysbiosis. Together, these data confirm the relationship between intestinal complement and the microbiome and shows that the classical complement system is activated to protect the host during microbial dysbiosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.